Evidence map›Paper›PMID 28448572›Full record

ArticlePloS one2017

Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital.

Elias Dahdouh, Rosa Gómez-Gil, Sonsoles Pacho, Jesús Mingorance, Ziad Daoud, Monica Suárez

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Carbapenem-ResistantMicroorganisms · 2025
    Review
  2. The context of blaBMC research notes · 2024
    Article
  3. Article
  4. Microorganisms · 2023
    Article
  5. Review
  6. Microbiology spectrum · 2022
    Article
  7. Extensively drug-resistant Acinetobacter baumannii carrying blaEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Molecular Epidemiology ofFrontiers in microbiology · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Dynamics of a Sporadic NosocomialFrontiers in microbiology · 2019
    Article
  18. Surface-Related Features and Virulence AmongFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Elias DahdouhDepartment of Animal Health, Faculty of Veterinary, Universidad Complutense de Madrid, Madrid, Spain.ORCID http://orcid.org/0000-0003-2309-4129
Rosa Gómez-GilServicio de Microbiología, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Sonsoles PachoDepartment of Animal Health, Faculty of Veterinary, Universidad Complutense de Madrid, Madrid, Spain.
Jesús MingoranceServicio de Microbiología, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.ORCID http://orcid.org/0000-0001-6173-5711
Ziad DaoudDepartment of Clinical Microbiology, Faculty of Medicine, University of Balamand, Balamand, Lebanon.
Monica SuárezDepartment of Animal Health, Faculty of Veterinary, Universidad Complutense de Madrid, Madrid, Spain.
Universidad Complutense de Madrid · ESHospital Universitario La Paz · ESUniversity of Balamand · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcinetobacter baumannii is a nosocomial pathogen that is showing increasing rates of carbapenem resistance. Multi-Drug Resistant (MDR) International Clones (ICs), associated with certain oxacillinases, are being reported globally. This organism also harbors numerous virulence determinants. In this study, we aim at characterizing A. baumannii isolated from a Spanish hospital in terms of antimicrobial susceptibility, clonality, carbapenemase genes harbored, and virulence determinants expressed. MATERIALS AND

methodsFifty nine clinical bloodstream isolates were obtained from 2009 until 2013. Antimicrobial Susceptibility Testing was performed according to the CLSI guidelines. PFGE and tri-locus PCR typing were then performed in order to determine local and international clonality. PCRs for the detection of common carbapenemases were also performed. Production of hemolysis, biofilms, siderophores, surface motility, and proteolysis were determined phenotypically. Doubling times for selected strains were also calculated. Finally, statistical analysis for detecting associations between these factors was conducted. RESULTS AND DISCUSSION: Carbapenem non-susceptibility was 84.75%, suggesting the immediate need for intervention. PFGE showed the distribution of the majority of the isolates among 7 clusters. Although all three ICs were detected, IC II was predominant at 71.19%. blaOXA-24-like was the most prevalent carbapenemase (62.71%), followed by blaOXA-58-like (13.56%), and blaOXA-23-like (11.86%). Strains pertaining to IC II, and those harboring blaOXA-24-like, were positively associated with α-hemolysis, production of strong biofilms, and siderophore production. Harboring blaOXA-23-like and blaOXA-58-like was associated with attenuated virulence. These associations suggest that an interplay exists between these factors that could be locally exploited.

conclusionsAn alarmingly high rate of carbapenem non-susceptibility has been detected in this study. There was a predominance of IC II and blaOXA-24-like, and those factors were associated with heightened expression of virulence determinants. This association could be exploited for modifying treatment regimens and for improving on infection control protocols in this hospital.

Indexed as

Acinetobacter baumanniiBacterial Proteinsbeta-LactamasesCarbapenemsClone CellsDrug Resistance, BacterialMicrobial Sensitivity TestsSpainVirulenceBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenems

Identifiers

PMID28448572
PMCPMC5407824
OpenAlexW2607689192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.